[1] MILLER BJ,GAO Y,DUCHMAN KR.Socioeconomic measures influence survival in osteosarcoma:An analysis of the National Cancer Data Base[J].Cancer Epidemiol,2017,49:112-117.
[2] FAISHAM WI,AZ MAT SAAD,LN ALSAIGH,et al.Prognostic factors and survival rate of osteosarcoma:A single-institution study[J].Asia Pac J Clin Oncol,2017,13(2):e104-e110.
[3] PARKER NJ,BEGLEY CG,SMITH PJ,et al.Molecular cloning of a novel human gene (D11S4896E) at chromosomal region 11p15.5[J].Genomics,1996,37(2):253-256.
[4] MOCCIA F,R BERRA-ROMANI,ROSTI V.Manipulating intracellular Ca2+ signals to stimulate therapeutic angiogenesis in cardiovascular disorders[J].Curr Pharm Biotechnol,2018,19(9):686-699.
[5] YANG Y,JIANG Z,WANG B,et al.Expression of STIM1 is associated with tumor aggressiveness and poor prognosis in breast cancer[J].Pathol Res Pract,2017,213(9):1043-1047.
[6] TANG BD,XIA X,LV XF,et al.Inhibition of Orai1-mediated Ca2+ entry enhances chemosensitivity of HepG2 hepatocarcinoma cells to 5-fluorouracil[J].J Cell Mol Med,2017,21(5):904-915.
[7] WANG Y,BAO X,ZHANG Z,et al.FGF2 promotes metastasis of uveal melanoma cells via store-operated calcium entry[J].Onco Targets Ther,2017,10:5317-5328.
[8] LIN YH,JEWELL BE,GINGOLD J,et al.Osteosarcoma:molecular pathogenesis and iPSC modeling[J].Trends Mol Med,2017,23(8):737-755.
[9] ZHENG Y,WANG G,CHEN R,et al.Mesenchymal stem cells in the osteosarcoma microenvironment:their biological properties,influence on tumor growth,and therapeutic implications[J].Stem Cell Res Ther,2018,9(1):22.
[10] ZHOU Y,GU P,LI J,et al.Suppression of STIM1 inhibits the migration and invasion of human prostate cancer cells and is associated with PI3K/Akt signaling inactivation[J].Oncol Rep,2017,38(5):2629-2636.
[11] WANG Y,WANG H,PAN T,et al.STIM1 silencing inhibits the migration and invasion of A549 cells[J].Mol Med Rep,2017,16(3):3283-3289.
[12] PIPERIGKOU Z,MANOU D,KARAMANOU K,et al.Strategies to target matrix metalloproteinases as therapeutic approach in cancer[J].Methods Mol Biol,2018,1731:325-348.
[13] WANG X,YANG B,SHE Y,et al.The lncRNA TP73-AS1 promotes ovarian cancer cell proliferation and metastasis via modulation of MMP2 and MMP9[J].J Cell Biochem,2018,119(9):7790-7799.
[14] WANG X,WANG B,XIE J,et al.Melatonin inhibits epithelial to mesenchymal transition in gastric cancer cells via attenuation of IL1beta/NFkappaB/MMP2/MMP9 signaling[J].Int J Mol Med,2018,42(4):2221-2228.
[15] QIN H,LIU X,LI F,et al.PAD1 promotes epithelial-mesenchymal transition and metastasis in triple-negative breast cancer cells by regulating MEK1-ERK1/2-MMP2 signaling[J].Cancer Lett,2017,409:30-41.
[16] YANG F,YU N,WANG H,et al.Downregulated expression of hepatoma-derived growth factor inhibits migration and invasion of prostate cancer cells by suppressing epithelial-mesenchymal transition and MMP2,MMP9[J].PLoS One,2018,13(1):e0190725.
[17] ZHU KP,MA XL,ZHANG CL.LncRNA ODRUL contributes to osteosarcoma progression through the miR-3182/MMP2 axis[J].Mol Ther,2017,25(10):2383-2393.
[18] LIU Z,LIU Z,ZHANG Y,et al.miR-24 represses metastasis of human osteosarcoma cells by targeting Ack1 via AKT/MMPs pathway[J].Biochem Biophys Res Commun,2017,486(2):211-217.
[19] ZHOU J,LIU T,WANG W.Prognostic significance of matrix metalloproteinase 9 expression in osteosarcoma:A meta-analysis of 16 studies[J].Medicine (Baltimore),2018,97(44):e13051.
[20] LIU H,HAO Y,ZHAO Z,et al.Sirtuin 6 contributes to migration and invasion of osteosarcoma cells via the ERK1/2/MMP9 pathway[J].FEBS Open Bio,2017,7(9):1291-1301.